Knowledge is power. Are you facing a new diagnosis or recurrence of Liver Cancer? The GI Connection Liver Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Liver Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Liver Cancer.
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
November 13, 2018
According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment […]
August 20, 2018
The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with […]
July 12, 2018
Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 […]
February 20, 2018
CancerConnect News: Treatment with Cabometyx (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest […]
February 15, 2018
CancerConnect News: According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an […]
May 18, 2017
Results from the CheckMate 040 clinical trial have been recently reported and found that Opdivo (nivolumab), an immuno-oncology drug which […]
May 8, 2017
The US Food and Drug Administration (FDA) has expanded the indication for Stivarga (regorafenib) to now include treatment for patients […]